269 related articles for article (PubMed ID: 35572149)
1. AD Resemblance Atrophy Index of Brain Magnetic Resonance Imaging in Predicting the Progression of Mild Cognitive Impairment Carrying Apolipoprotein E-ε4 Allele.
Mai Y; Cao Z; Xu J; Yu Q; Yang S; Tang J; Zhao L; Fang W; Luo Y; Lei M; Mok VCT; Shi L; Liao W; Liu J;
Front Aging Neurosci; 2022; 14():859492. PubMed ID: 35572149
[TBL] [Abstract][Full Text] [Related]
2. Association of CSF GAP-43 and
Zhu Y; Guo X; Zhu F; Zhang Q; Yang Y; For The Alzheimer's Disease Neuroimaging Initiative
Cells; 2022 Dec; 12(1):. PubMed ID: 36611808
[TBL] [Abstract][Full Text] [Related]
3. Low testosterone levels relate to poorer cognitive function in women in an APOE-ε4-dependant manner.
Dratva MA; Banks SJ; Panizzon MS; Galasko D; Sundermann EE;
Biol Sex Differ; 2024 Jun; 15(1):45. PubMed ID: 38835072
[TBL] [Abstract][Full Text] [Related]
4. The Effects of CSF Neurogranin and
Fan Y; Gao Y; Therriault J; Luo J; Ba M; Zhang H;
Front Aging Neurosci; 2021; 13():667899. PubMed ID: 33986657
[TBL] [Abstract][Full Text] [Related]
5. APOE ε4/ε4 homozygotes with early Alzheimer's disease show accelerated hippocampal atrophy and cortical thinning that correlates with cognitive decline.
Abushakra S; Porsteinsson AP; Sabbagh M; Bracoud L; Schaerer J; Power A; Hey JA; Scott D; Suhy J; Tolar M;
Alzheimers Dement (N Y); 2020; 6(1):e12117. PubMed ID: 33304988
[TBL] [Abstract][Full Text] [Related]
6. The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI).
Risacher SL; Kim S; Shen L; Nho K; Foroud T; Green RC; Petersen RC; Jack CR; Aisen PS; Koeppe RA; Jagust WJ; Shaw LM; Trojanowski JQ; Weiner MW; Saykin AJ;
Front Aging Neurosci; 2013; 5():11. PubMed ID: 23554593
[TBL] [Abstract][Full Text] [Related]
7. Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.
Pyun JM; Park YH; Lee KJ; Kim S; Saykin AJ; Nho K;
Transl Neurodegener; 2021 Aug; 10(1):32. PubMed ID: 34465370
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
[TBL] [Abstract][Full Text] [Related]
9. The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study.
Paranjpe MD; Chen X; Liu M; Paranjpe I; Leal JP; Wang R; Pomper MG; Wong DF; Benzinger TLS; Zhou Y;
Neuroimage Clin; 2019; 22():101795. PubMed ID: 30991617
[TBL] [Abstract][Full Text] [Related]
10. Sex modulates the ApoE ε4 effect on brain tau deposition measured by
Liu M; Paranjpe MD; Zhou X; Duy PQ; Goyal MS; Benzinger TLS; Lu J; Wang R; Zhou Y
Theranostics; 2019; 9(17):4959-4970. PubMed ID: 31410194
[TBL] [Abstract][Full Text] [Related]
11. Effect of apolipoprotein E ε4 allele on the progression of cognitive decline in the early stage of Alzheimer's disease.
Suzuki K; Hirakawa A; Ihara R; Iwata A; Ishii K; Ikeuchi T; Sun CK; Donohue M; Iwatsubo T;
Alzheimers Dement (N Y); 2020; 6(1):e12007. PubMed ID: 32211510
[TBL] [Abstract][Full Text] [Related]
12. Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid.
Falahati F; Ferreira D; Muehlboeck JS; Eriksdotter M; Simmons A; Wahlund LO; Westman E
Neuroimage Clin; 2017; 16():418-428. PubMed ID: 28879083
[TBL] [Abstract][Full Text] [Related]
13. Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment.
Okonkwo OC; Alosco ML; Jerskey BA; Sweet LH; Ott BR; Tremont G;
Alzheimers Dement; 2010 Sep; 6(5):404-11. PubMed ID: 20813341
[TBL] [Abstract][Full Text] [Related]
14. APOE ε4 increases the risk of progression from amnestic mild cognitive impairment to Alzheimer's disease among ethnic Chinese in Taiwan.
Wang PN; Hong CJ; Lin KN; Liu HC; Chen WT
J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):165-9. PubMed ID: 20660919
[TBL] [Abstract][Full Text] [Related]
15. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in the association of APOE ε4 genotype with longitudinal hippocampal atrophy in cognitively normal older people.
Shen S; Zhou W; Chen X; Zhang J;
Eur J Neurol; 2019 Nov; 26(11):1362-1369. PubMed ID: 31102429
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.
Elias-Sonnenschein LS; Viechtbauer W; Ramakers IH; Verhey FR; Visser PJ
J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1149-56. PubMed ID: 21493755
[TBL] [Abstract][Full Text] [Related]
18. Racial differences in the effect of APOE-ε4 genotypes on trail making test B in Alzheimer's disease: A longitudinal study.
Xu C; Acevedo P; Lu Y; Su BB; Ozuna K; Padilla V; Karithara A; Mao C; Navia RO; Piamjariyakul U; Wang K;
Int J Geriatr Psychiatry; 2023 Dec; 38(12):e6037. PubMed ID: 38100638
[TBL] [Abstract][Full Text] [Related]
19. The Role of Apolipoprotein E ε4 in Early and Late Mild Cognitive Impairment.
Luo Y; Tan L; Therriault J; Zhang H; Gao Y;
Eur Neurol; 2021; 84(6):472-480. PubMed ID: 34340229
[TBL] [Abstract][Full Text] [Related]
20. Brain Homotopic Connectivity in Mild Cognitive Impairment APOE-ε4 Carriers.
Shi JY; Wang P; Wang BH; Xu Y; Chen X; Li HJ
Neuroscience; 2020 Jun; 436():74-81. PubMed ID: 32304722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]